|
1
|
Yang C, Kim HS, Song G and Lim W: The
potential role of exosomes derived from ovarian cancer cells for
diagnostic and therapeutic approaches. J Cell Physiol.
234:21493–21503. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Stewart C, Ralyea C and Lockwood S:
Ovarian cancer: An integrated review. Semin Oncol Nurs. 35:151–156.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Koshiyama M, Matsumura N and Konishi I:
Subtypes of ovarian cancer and ovarian cancer screening.
Diagnostics (Basel). 7:122017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lheureux S, Braunstein M and Oza AM:
Epithelial ovarian cancer: Evolution of management in the era of
precision medicine. CA Cancer J Clin. 69:280–304. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lisio MA, Fu L, Goyeneche A, Gao ZH and
Telleria C: High-grade serous ovarian cancer: Basic sciences,
clinical and therapeutic standpoints. Int J Mol Sci. 20:9522019.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sierra J, Marrugo-Ramirez J,
Rodríguez-Trujillo R, Mir M and Samitier J: Sensor-integrated
microfluidic approaches for liquid biopsies applications in early
detection of cancer. Sensors (Basel). 20:13172020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bellassai N, D'Agata R, Jungbluth V and
Spoto G: Surface plasmon resonance for biomarker detection:
Advances in non-invasive cancer diagnosis. Front Chem. 7:5702019.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Miao M, Miao Y, Zhu Y, Wang J and Zhou H:
Advances in exosomes as diagnostic and therapeutic biomarkers for
gynaecological malignancies. Cancers (Basel). 14:47432022.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Maurano MT, Humbert R, Rynes E, Thurman
RE, Haugen E, Wang H, Reynolds AP, Sandstrom R, Qu H, Brody J, et
al: Systematic localization of common disease-associated variation
in regulatory DNA. Science. 337:1190–1195. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Morris KV and Mattick JS: The rise of
regulatory RNA. Nat Rev Genet. 15:423–437. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hauptman N and Glavač D: Long non-coding
RNA in cancer. Int J Mol Sci. 14:4655–4669. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lander ES, Linton LM, Birren B, Nusbaum C,
Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, et al:
Initial sequencing and analysis of the human genome. Nature.
409:860–921. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Beg A, Parveen R, Fouad H, Yahia ME and
Hassanein AS: Role of different non-coding RNAs as ovarian cancer
biomarkers. J Ovarian Res. 15:722022. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fu G, Brkić J, Hayder H and Peng C:
MicroRNAs in human placental development and pregnancy
complications. Int J Mol Sci. 14:5519–5544. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Weber JA, Baxter DH, Zhang S, Huang DY,
Huang KH, Lee MJ, Galas DJ and Wang K: The microRNA spectrum in 12
body fluids. Clin Chem. 56:1733–1741. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Théry C: Exosomes: Secreted vesicles and
intercellular communications. F1000 Biol Rep. 3:152011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Théry C, Zitvogel L and Amigorena S:
Exosomes: Composition, biogenesis and function. Nat Rev Immunol.
2:569–579. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Iyer MK, Niknafs YS, Malik R, Singhal U,
Sahu A, Hosono Y, Barrette TR, Prensner JR, Evans JR, Zhao S, et
al: The landscape of long noncoding RNAs in the human
transcriptome. Nat Genet. 47:199–208. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang KC and Chang HY: Molecular mechanisms
of long noncoding RNAs. Mol Cell. 43:904–914. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Guo X, Gao Y, Song Q, Wei J, Wu J, Dong J,
Chen L, Xu S, Wu D, Yang X, et al: Early assessment of circulating
exosomal lncRNA-GC1 for monitoring neoadjuvant chemotherapy
response in gastric cancer. Int J Surg. 109:1094–1104. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Obi P and Chen YG: The design and
synthesis of circular RNAs. Methods. 196:85–103. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen LL: The expanding regulatory
mechanisms and cellular functions of circular RNAs. Nat Rev Mol
Cell Biol. 21:475–490. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pan BT, Teng K, Wu C, Adam M and Johnstone
RM: Electron microscopic evidence for externalization of the
transferrin receptor in vesicular form in sheep reticulocytes. J
Cell Biol. 101:942–948. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Isaac R, Reis FCG, Ying W and Olefsky JM:
Exosomes as mediators of intercellular crosstalk in metabolism.
Cell Metab. 33:1744–1762. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Qi Y, Xu R, Song C, Hao M, Gao Y, Xin M,
Liu Q, Chen H, Wu X, Sun R, et al: A comprehensive database of
exosome molecular biomarkers and disease-gene associations. Sci
Data. 11:2102024. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kalluri R and McAndrews KM: The role of
extracellular vesicles in cancer. Cell. 186:1610–1626. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mannelli C: Tissue vs liquid biopsies for
cancer detection: Ethical issues. J Bioeth Inq. 16:551–557. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xie H and Kim RD: The application of
circulating tumor DNA in the screening, surveillance, and treatment
monitoring of colorectal cancer. Ann Surg Oncol. 28:1845–1858.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang WL, Lu Z, Guo J, Fellman BM, Ning J,
Lu KH, Menon U, Kobayashi M, Hanash SM, Celestino J, et al: Human
epididymis protein 4 antigen-autoantibody complexes complement
cancer antigen 125 for detecting early-stage ovarian cancer.
Cancer. 126:725–736. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yu W, Hurley J, Roberts D, Chakrabortty
SK, Enderle D, Noerholm M, Breakefield XO and Skog JK:
Exosome-based liquid biopsies in cancer: Opportunities and
challenges. Ann Oncol. 32:466–477. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kalluri R: The biology and function of
exosomes in cancer. J Clin Invest. 126:1208–1215. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Spina V and Rossi D: Liquid biopsy in
tissue-born lymphomas. Swiss Med Wkly. 149:w147092019.PubMed/NCBI
|
|
34
|
Lianidou ES, Mavroudis D, Sotiropoulou G,
Agelaki S and Pantel K: What's new on circulating tumor cells? A
meeting report. Breast Cancer Res. 12:3072010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shigeyasu K, Toden S, Zumwalt TJ, Okugawa
Y and Goel A: Emerging role of MicroRNAs as liquid biopsy
biomarkers in gastrointestinal cancers. Clin Cancer Res.
23:2391–2399. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ebrahimi N, Faghihkhorasani F, Fakhr SS,
Moghaddam PR, Yazdani E, Kheradmand Z, Rezaei-Tazangi F, Adelian S,
Mobarak H, Hamblin MR and Aref AR: Tumor-derived exosomal
non-coding RNAs as diagnostic biomarkers in cancer. Cell Mol Life
Sci. 79:5722022. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kalluri R and LeBleu VS: The biology,
function, and biomedical applications of exosomes. Science.
367:eaau69772020. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li C, Ni YQ, Xu H, Xiang QY, Zhao Y, Zhan
JK, He JY, Li S and Liu YS: Roles and mechanisms of exosomal
non-coding RNAs in human health and diseases. Signal Transduct
Target Ther. 6:3832021. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jacobs IJ, Menon U, Ryan A, Gentry-Maharaj
A, Burnell M, Kalsi JK, Amso NN, Apostolidou S, Benjamin E,
Cruickshank D, et al: Ovarian cancer screening and mortality in the
UK collaborative trial of ovarian cancer screening (UKCTOCS): A
randomised controlled trial. Lancet. 387:945–956. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Anastasiadou E, Jacob LS and Slack FJ:
Non-coding RNA networks in cancer. Nat Rev Cancer. 18:5–18. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lee RC, Feinbaum RL and Ambros V: The C.
elegans heterochronic gene lin-4 encodes small RNAs with antisense
complementarity to lin-14. Cell. 75:843–854. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Gareev I, Beylerli O, Yang G, Sun J,
Pavlov V, Izmailov A, Shi H and Zhao S: The current state of MiRNAs
as biomarkers and therapeutic tools. Clin Exp Med. 20:349–359.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
O'Brien J, Hayder H, Zayed Y and Peng C:
Overview of MicroRNA biogenesis, mechanisms of actions, and
circulation. Front Endocrinol (Lausanne). 9:4022018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Toden S and Goel A: Non-coding RNAs as
liquid biopsy biomarkers in cancer. Br J Cancer. 126:351–360. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhang Z, Qin YW, Brewer G and Jing Q:
MicroRNA degradation and turnover: Regulating the regulators. Wiley
Interdiscip Rev RNA. 3:593–600. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ha M and Kim VN: Regulation of microRNA
biogenesis. Nat Rev Mol Cell Biol. 15:509–524. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Denli AM, Tops BB, Plasterk RHA, Ketting
RF and Hannon GJ: Processing of primary microRNAs by the
Microprocessor complex. Nature. 432:231–235. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Han J, Lee Y, Yeom KH, Kim YK, Jin H and
Kim VN: The Drosha-DGCR8 complex in primary microRNA processing.
Genes Dev. 18:3016–3027. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yoda M, Kawamata T, Paroo Z, Ye X, Iwasaki
S, Liu Q and Tomari Y: ATP-dependent human RISC assembly pathways.
Nat Struct Mol Biol. 17:17–23. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Broughton JP, Lovci MT, Huang JL, Yeo GW
and Pasquinelli AE: Pairing beyond the seed supports MicroRNA
targeting specificity. Mol Cell. 64:320–333. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Braun JE, Huntzinger E and Izaurralde E:
The role of GW182 proteins in miRNA-mediated gene silencing. Adv
Exp Med Biol. 768:147–163. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Hayder H, O'Brien J, Nadeem U and Peng C:
MicroRNAs: Crucial regulators of placental development.
Reproduction. 155:R259–R271. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Christie M, Boland A, Huntzinger E,
Weichenrieder O and Izaurralde E: Structure of the PAN3
pseudokinase reveals the basis for interactions with the PAN2
deadenylase and the GW182 proteins. Mol Cell. 51:360–373. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Vasudevan S and Steitz JA:
AU-rich-element-mediated upregulation of translation by FXR1 and
argonaute 2. Cell. 128:1105–1118. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Peng Y and Croce CM: The role of MicroRNAs
in human cancer. Signal Transduct Target Ther. 1:150042016.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Zhang B, Pan X, Cobb GP and Anderson TA:
microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Chou CH, Chang NW, Shrestha S, Hsu SD, Lin
YL, Lee WH, Yang CD, Hong HC, Wei TY, Tu SJ, et al: miRTarBase
2016: Updates to the experimentally validated miRNA-target
interactions database. Nucleic Acids Res. 44(D1): D239–D247. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Kang M, Tang B, Li J, Zhou Z, Liu K, Wang
R, Jiang Z, Bi F, Patrick D, Kim D, et al: Identification of
miPEP133 as a novel tumor-suppressor microprotein encoded by
miR-34a pri-miRNA. Mol Cancer. 19:1432020. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Zhang WC, Chin TM, Yang H, Nga ME, Lunny
DP, Lim EK, Sun LL, Pang YH, Leow YN, Malusay SR, et al:
Tumour-initiating cell-specific miR-1246 and miR-1290 expression
converge to promote non-small cell lung cancer progression. Nat
Commun. 7:117022016. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Chai S, Ng KY, Tong M, Lau EY, Lee TK,
Chan KW, Yuan YF, Cheung TT, Cheung ST, Wang XQ, et al: Octamer 4/
microRNA-1246 signaling axis drives Wnt/β-catenin activation in
liver cancer stem cells. Hepatology. 64:2062–2076. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Cooks T, Pateras IS, Jenkins LM, Patel KM,
Robles AI, Morris J, Forshew T, Appella E, Gorgoulis VG and Harris
CC: Mutant p53 cancers reprogram macrophages to tumor supporting
macrophages via exosomal miR-1246. Nat Commun. 9:7712018.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Wang W, Jo H, Park S, Kim H, Kim SI, Han
Y, Lee J, Seol A, Kim J, Lee M, et al: Integrated analysis of
ascites and plasma extracellular vesicles identifies a miRNA-based
diagnostic signature in ovarian cancer. Cancer Lett.
542:2157352022. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Kanlikilicer P, Bayraktar R, Denizli M,
Rashed MH, Ivan C, Aslan B, Mitra R, Karagoz K, Bayraktar E, Zhang
X, et al: Exosomal miRNA confers chemo resistance via targeting
Cav1/p-gp/M2-type macrophage axis in ovarian cancer. EBioMedicine.
38:100–112. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Yamashita R, Sato M, Kakumu T, Hase T,
Yogo N, Maruyama E, Sekido Y, Kondo M and Hasegawa Y: Growth
inhibitory effects of miR-221 and miR-222 in non-small cell lung
cancer cells. Cancer Med. 4:551–564. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Li J, Li Q, Huang H, Li Y, Li L, Hou W and
You Z: Overexpression of miRNA-221 promotes cell proliferation by
targeting the apoptotic protease activating factor-1 and indicates
a poor prognosis in ovarian cancer. Int J Oncol. 50:1087–1096.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Liu CH, Jing XN, Liu XL, Qin SY, Liu MW
and Hou CH: Tumor-suppressor miRNA-27b-5p regulates the growth and
metastatic behaviors of ovarian carcinoma cells by targeting CXCL1.
J Ovarian Res. 13:922020. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Cancer Genome Atlas Research Network, .
Integrated genomic analyses of ovarian carcinoma. Nature.
474:609–615. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Tothill RW, Tinker AV, George J, Brown R,
Fox SB, Lade S, Johnson DS, Trivett MK, Etemadmoghadam D, Locandro
B, et al: Novel molecular subtypes of serous and endometrioid
ovarian cancer linked to clinical outcome. Clin Cancer Res.
14:5198–5208. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Liu R, Hu R, Zeng Y, Zhang W and Zhou HH:
Tumour immune cell infiltration and survival after platinum-based
chemotherapy in high-grade serous ovarian cancer subtypes: A gene
expression-based computational study. EBioMedicine. 51:1026022020.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Yang Z, Wang W, Zhao L, Wang X, Gimple RC,
Xu L, Wang Y, Rich JN and Zhou S: Plasma cells shape the
mesenchymal identity of ovarian cancers through transfer of
exosome-derived microRNAs. Sci Adv. 7:eabb07372021. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Brannan CI, Dees EC, Ingram RS and
Tilghman SM: The product of the H19 gene may function as an RNA.
Mol Cell Biol. 10:28–36. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Zhao L, Sun W, Zheng A, Zhang Y, Fang C
and Zhang P: Ginsenoside Rg3 suppresses ovarian cancer cell
proliferation and invasion by inhibiting the expression of lncRNA
H19. Acta Biochim Pol. 68:575–582. 2021.PubMed/NCBI
|
|
74
|
Hartford CCR and Lal A: When long
noncoding becomes protein coding. Mol Cell Biol. 40:e00528–19.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Quinn JJ and Chang HY: Unique features of
long non-coding RNA biogenesis and function. Nat Rev Genet.
17:47–62. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Ransohoff JD, Wei Y and Khavari PA: The
functions and unique features of long intergenic non-coding RNA.
Nat Rev Mol Cell Biol. 19:143–157. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Mattick JS, Amaral PP, Carninci P,
Carpenter S, Chang HY, Chen LL, Chen R, Dean C, Dinger ME,
Fitzgerald KA, et al: Long non-coding RNAs: Definitions, functions,
challenges and recommendations. Nat Rev Mol Cell Biol. 24:430–447.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
St Laurent G, Wahlestedt C and Kapranov P:
The Landscape of long noncoding RNA classification. Trends Genet.
31:239–251. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Wang H, Meng Q, Qian J, Li M, Gu C and
Yang Y: Review: RNA-based diagnostic markers discovery and
therapeutic targets development in cancer. Pharmacol Ther.
234:1081232022. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Kopp F and Mendell JT: Functional
classification and experimental dissection of long noncoding RNAs.
Cell. 172:393–407. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Graf J and Kretz M: From structure to
function: Route to understanding lncRNA mechanism. Bioessays.
42:e20000272020. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Seetin MG and Mathews DH: RNA structure
prediction: An overview of methods. Methods Mol Biol. 905:99–122.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Lampropoulou DI, Papadimitriou M,
Papadimitriou C, Filippou D, Kourlaba G, Aravantinos G and Gazouli
M: The role of EMT-related lncRNAs in ovarian cancer. Int J Mol
Sci. 24:100792023. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Liang H, Yu T, Han Y, Jiang H, Wang C, You
T, Zhao X, Shan H, Yang R, Yang L, et al: LncRNA PTAR promotes EMT
and invasion-metastasis in serous ovarian cancer by competitively
binding miR-101-3p to regulate ZEB1 expression. Mol Cancer.
17:1192018. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Leung D, Price ZK, Lokman NA, Wang W,
Goonetilleke L, Kadife E, Oehler MK, Ricciardelli C, Kannourakis G
and Ahmed N: Platinum-resistance in epithelial ovarian cancer: An
interplay of epithelial-mesenchymal transition interlinked with
reprogrammed metabolism. J Transl Med. 20:5562022. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Kralj J, Pernar Kovač M, Dabelić S,
Polančec DS, Wachtmeister T, Köhrer K and Brozovic A: Transcriptome
analysis of newly established carboplatin-resistant ovarian cancer
cell model reveals genes shared by drug resistance and drug-induced
EMT. Br J Cancer. 128:1344–1359. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Teschendorff AE, Lee SH, Jones A, Fiegl H,
Kalwa M, Wagner W, Chindera K, Evans I, Dubeau L, Orjalo A, et al:
HOTAIR and its surrogate DNA methylation signature indicate
carboplatin resistance in ovarian cancer. Genome Med. 7:1082015.
View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Gupta RA, Shah N, Wang KC, Kim J, Horlings
HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al: Long
non-coding RNA HOTAIR reprograms chromatin state to promote cancer
metastasis. Nature. 464:1071–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Bernstein BE, Mikkelsen TS, Xie X, Kamal
M, Huebert DJ, Cuff J, Fry B, Meissner A, Wernig M, Plath K, et al:
A bivalent chromatin structure marks key developmental genes in
embryonic stem cells. Cell. 125:315–326. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Lee TI, Jenner RG, Boyer LA, Guenther MG,
Levine SS, Kumar RM, Chevalier B, Johnstone SE, Cole MF, Isono K,
et al: Control of developmental regulators by polycomb in human
embryonic stem cells. Cell. 125:301–313. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Teschendorff AE, Menon U, Gentry-Maharaj
A, Ramus SJ, Weisenberger DJ, Shen H, Campan M, Noushmehr H, Bell
CG, Maxwell AP, et al: Age-dependent DNA methylation of genes that
are suppressed in stem cells is a hallmark of cancer. Genome Res.
20:440–446. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Qiu JJ, Lin YY, Ye LC, Ding JX, Feng WW,
Jin HY, Zhang Y, Li Q and Hua KQ: Overexpression of long non-coding
RNA HOTAIR predicts poor patient prognosis and promotes tumor
metastasis in epithelial ovarian cancer. Gynecol Oncol.
134:121–128. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Yang S, Ji J, Wang M, Nie J and Wang S:
Construction of ovarian cancer prognostic model based on the
investigation of ferroptosis-related lncRNA. Biomolecules.
13:3062023. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Jin Y, Qiu J, Lu X, Ma Y and Li G: LncRNA
CACNA1G-AS1 up-regulates FTH1 to inhibit ferroptosis and promote
malignant phenotypes in ovarian cancer cells. Oncol Res.
31:169–179. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Cai L, Hu X, Ye L, Bai P, Jie Y and Shu K:
Long non-coding RNA ADAMTS9-AS1 attenuates ferroptosis by Targeting
microRNA-587/solute carrier family 7 member 11 axis in epithelial
ovarian cancer. Bioengineered. 13:8226–8239. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Liu F, Cao L, Zhang Y, Xia X and Ji Y:
LncRNA LIFR-AS1 overexpression suppressed the progression of serous
ovarian carcinoma. J Clin Lab Anal. 36:e254702022. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Lin X, Feng D, Li P and Lv Y: LncRNA
LINC00857 regulates the progression and glycolysis in ovarian
cancer by modulating the Hippo signaling pathway. Cancer Med.
9:8122–8132. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Sanger HL, Klotz G, Riesner D, Gross HJ
and Kleinschmidt AK: Viroids are single-stranded covalently closed
circular RNA molecules existing as highly base-paired rod-like
structures. Proc Natl Acad Sci USA. 73:3852–3856. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Li Y, Zheng Q, Bao C, Li S, Guo W, Zhao J,
Chen D, Gu J, He X and Huang S: Circular RNA is enriched and stable
in exosomes: A promising biomarker for cancer diagnosis. Cell Res.
25:981–984. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Meng X, Li X, Zhang P, Wang J, Zhou Y and
Chen M: Circular RNA: An emerging key player in RNA world. Brief
Bioinform. 18:547–557. 2017.PubMed/NCBI
|
|
101
|
Patop IL, Wüst S and Kadener S: Past,
present, and future of circRNAs. EMBO J. 38:e1008362019. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Yao T, Chen Q, Fu L and Guo J: Circular
RNAs: Biogenesis, properties, roles, and their relationships with
liver diseases. Hepatol Res. 47:497–504. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Lasda E and Parker R: Circular RNAs
co-precipitate with extracellular vesicles: A possible mechanism
for circRNA clearance. PLoS One. 11:e01484072016. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Ngo LH, Bert AG, Dredge BK, Williams T,
Murphy V, Li W, Hamilton WB, Carey KT, Toubia J, Pillman KA, et al:
Nuclear export of circular RNA. Nature. 627:212–220. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Pisignano G, Michael DC, Visal TH, Pirlog
R, Ladomery M and Calin GA: Going circular: History, present, and
future of circRNAs in cancer. Oncogene. 42:2783–2800. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Jeck WR, Sorrentino JA, Wang K, Slevin MK,
Burd CE, Liu J, Marzluff WF and Sharpless NE: Circular RNAs are
abundant, conserved, and associated with ALU repeats. RNA.
19:141–157. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Shang Q, Yang Z, Jia R and Ge S: The novel
roles of circRNAs in human cancer. Mol Cancer. 18:62019. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Ye D, Gong M, Deng Y, Fang S, Cao Y, Xiang
Y and Shen Z: Roles and clinical application of exosomal circRNAs
in the diagnosis and treatment of malignant tumors. J Transl Med.
20:1612022. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Su M, Xiao Y, Ma J, Tang Y, Tian B, Zhang
Y, Li X, Wu Z, Yang D, Zhou Y, et al: Circular RNAs in cancer:
Emerging functions in hallmarks, stemness, resistance and roles as
potential biomarkers. Mol Cancer. 18:902019. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Cortes R and Forner MJ: Circular RNAS:
Novel biomarkers of disease activity in systemic lupus
erythematosus? Clin Sci (Lond). 133:1049–1052. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Liu CX and Chen LL: Circular RNAs:
Characterization, cellular roles, and applications. Cell.
185:2016–2034. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Lei M, Zheng G, Ning Q, Zheng J and Dong
D: Translation and functional roles of circular RNAs in human
cancer. Mol Cancer. 19:302020. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Zhao Q, Liu J, Deng H, Ma R, Liao JY,
Liang H, Hu J, Li J, Guo Z, Cai J, et al: Targeting
mitochondria-located circRNA SCAR alleviates NASH via reducing mROS
output. Cell. 183:76–93.e22. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Huang D, Zhu X, Ye S, Zhang J, Liao J,
Zhang N, Zeng X, Wang J, Yang B, Zhang Y, et al: Tumour circular
RNAs elicit anti-tumour immunity by encoding cryptic peptides.
Nature. 625:593–602. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Li H, Lin R, Zhang Y, Zhu Y, Huang S, Lan
J, Lu N, Xie C, He S and Zhang W: N6-methyladenosine-modified
circPLPP4 sustains cisplatin resistance in ovarian cancer cells via
PIK3R1 upregulation. Mol Cancer. 23:52024. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Zhou X, Jiang J and Guo S:
Hsa_circ_0004712 downregulation attenuates ovarian cancer malignant
development by targeting the miR-331-3p/FZD4 pathway. J Ovarian
Res. 14:1182021. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Camuzard O, Santucci-Darmanin S, Carle GF
and Pierrefite-Carle V: Autophagy in the crosstalk between tumor
and microenvironment. Cancer Lett. 490:143–153. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Ye J, Wu D, Wu P, Chen Z and Huang J: The
cancer stem cell niche: Cross talk between cancer stem cells and
their microenvironment. Tumour Biol. 35:3945–3951. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Kaplan RN, Riba RD, Zacharoulis S, Bramley
AH, Vincent L, Costa C, MacDonald DD, Jin DK, Shido K, Kerns SA, et
al: VEGFR1-positive haematopoietic bone marrow progenitors initiate
the pre-metastatic niche. Nature. 438:820–827. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Yue M, Hu S, Sun H, Tuo B, Jia B, Chen C,
Wang W, Liu J, Liu Y, Sun Z and Hu J: Extracellular vesicles
remodel tumor environment for cancer immunotherapy. Mol Cancer.
22:2032023. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Mei S, Chen X, Wang K and Chen Y: Tumor
microenvironment in ovarian cancer peritoneal metastasis. Cancer
Cell Int. 23:112023. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Lorusso D, Ceni V, Daniele G, Salutari V,
Pietragalla A, Muratore M, Nero C, Ciccarone F and Scambia G: Newly
diagnosed ovarian cancer: Which first-line treatment? Cancer Treat
Rev. 91:1021112020. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Mo Y, Leung LL, Mak CSL, Wang X, Chan WS,
Hui LMN, Tang HWM, Siu MKY, Sharma R, Xu D, et al: Tumor-secreted
exosomal miR-141 activates tumor-stroma interactions and controls
premetastatic niche formation in ovarian cancer metastasis. Mol
Cancer. 22:42023. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Yi H, Ye J, Yang XM, Zhang LW, Zhang ZG
and Chen YP: High-grade ovarian cancer secreting effective exosomes
in tumor angiogenesis. Int J Clin Exp Pathol. 8:5062–5070.
2015.PubMed/NCBI
|
|
125
|
Leary N, Walser S, He Y, Cousin N, Pereira
P, Gallo A, Collado-Diaz V, Halin C, Garcia-Silva S, Peinado H and
Dieterich LC: Melanoma-derived extracellular vesicles mediate
lymphatic remodelling and impair tumour immunity in draining lymph
nodes. J Extracell Vesicles. 11:e121972022. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Chen G, Huang AC, Zhang W, Zhang G, Wu M,
Xu W, Yu Z, Yang J, Wang B, Sun H, et al: Exosomal PD-L1
contributes to immunosuppression and is associated with anti-PD-1
response. Nature. 560:382–386. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Kelleher RJ Jr, Balu-Iyer S, Loyall J,
Sacca AJ, Shenoy GN, Peng P, Iyer V, Fathallah AM, Berenson CS,
Wallace PK, et al: Extracellular vesicles present in human ovarian
tumor microenvironments induce a phosphatidylserine-dependent
arrest in the T-cell signaling cascade. Cancer Immunol Res.
3:1269–1278. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Arenaccio C, Chiozzini C, Columba-Cabezas
S, Manfredi F, Affabris E, Baur A and Federico M: Exosomes from
human immunodeficiency virus type 1 (HIV-1)-infected cells license
quiescent CD4+ T lymphocytes to replicate HIV-1 through a Nef- and
ADAM17-dependent mechanism. J Virol. 88:11529–11539. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Lugini L, Cecchetti S, Huber V, Luciani F,
Macchia G, Spadaro F, Paris L, Abalsamo L, Colone M, Molinari A, et
al: Immune surveillance properties of human NK cell-derived
exosomes. J Immunol. 189:2833–2842. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Luo H, Zhou Y, Zhang J, Zhang Y, Long S,
Lin X, Yang A, Duan J, Yang N, Yang Z, et al: NK cell-derived
exosomes enhance the anti-tumor effects against ovarian cancer by
delivering cisplatin and reactivating NK cell functions. Front
Immunol. 13:10876892023. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Shiao MS, Chang JM, Lertkhachonsuk AA,
Rermluk N and Jinawath N: Circulating exosomal miRNAs as biomarkers
in epithelial ovarian cancer. Biomedicines. 9:14332021. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Buys SS, Partridge E, Black A, Johnson CC,
Lamerato L, Isaacs C, Reding DJ, Greenlee RT, Yokochi LA, Kessel B,
et al: Effect of screening on ovarian cancer mortality: The
prostate, lung, colorectal and ovarian (PLCO) cancer screening
randomized controlled trial. JAMA. 305:2295–2303. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Moss EL, Hollingworth J and Reynolds TM:
The role of CA125 in clinical practice. J Clin Pathol. 58:308–312.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Yokoi A, Yoshioka Y, Hirakawa A, Yamamoto
Y, Ishikawa M, Ikeda SI, Kato T, Niimi K, Kajiyama H, Kikkawa F and
Ochiya T: A combination of circulating miRNAs for the early
detection of ovarian cancer. Oncotarget. 8:89811–89823. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Wang S and Song X, Wang K, Zheng B, Lin Q,
Yu M, Xie L, Chen L and Song X: Plasma exosomal miR-320d, miR-4479,
and miR-6763-5p as diagnostic biomarkers in epithelial ovarian
cancer. Front Oncol. 12:9863432022. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Pan C, Stevic I, Müller V, Ni Q,
Oliveira-Ferrer L, Pantel K and Schwarzenbach H: Exosomal microRNAs
as tumor markers in epithelial ovarian cancer. Mol Oncol.
12:1935–1948. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Maeda K, Sasaki H, Ueda S, Miyamoto S,
Terada S, Konishi H, Kogata Y, Ashihara K, Fujiwara S, Tanaka Y, et
al: Serum exosomal microRNA-34a as a potential biomarker in
epithelial ovarian cancer. J Ovarian Res. 13:472020. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Qiu JJ, Lin XJ, Tang XY, Zheng TT, Lin YY
and Hua KQ: Exosomal metastasis-associated lung adenocarcinoma
transcript 1 promotes angiogenesis and predicts poor prognosis in
epithelial ovarian cancer. Int J Biol Sci. 14:1960–1973. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Zhang W, Su X, Li S, Liu Z, Wang Q and
Zeng H: Low serum exosomal miR-484 expression predicts unfavorable
prognosis in ovarian cancer. Cancer Biomark. 27:485–491. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Luo Y and Gui R: Circulating exosomal
circFoxp1 confers cisplatin resistance in epithelial ovarian cancer
cells. J Gynecol Oncol. 31:e752020. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Chowdhury S, Kennedy JJ, Ivey RG, Murillo
OD, Hosseini N, Song X, Petralia F, Calinawan A, Savage SR, Berry
AB, et al: Proteogenomic analysis of chemo-refractory high-grade
serous ovarian cancer. Cell. 186:3476–3498.e35. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Martínez-Greene JA, Gómez-Chavarín M,
Ramos-Godínez MDP and Martínez-Martínez E: Isolation of hepatic and
adipose-tissue-derived extracellular vesicles using density
gradient separation and size exclusion chromatography. Int J Mol
Sci. 24:127042023. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Bai HH, Wang XF, Zhang BY and Liu W: A
comparison of size exclusion chromatography-based tandem strategies
for plasma exosome enrichment and proteomic analysis. Anal Methods.
15:6245–6251. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Takov K, Yellon DM and Davidson SM:
Comparison of small extracellular vesicles isolated from plasma by
ultracentrifugation or size-exclusion chromatography: Yield, purity
and functional potential. J Extracell Vesicles. 8:15608092018.
View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Tian Y, Gong M, Hu Y, Liu H, Zhang W,
Zhang M, Hu X, Aubert D, Zhu S, Wu L and Yan X: Quality and
efficiency assessment of six extracellular vesicle isolation
methods by nano-flow cytometry. J Extracell Vesicles.
9:16970282019. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Aliakbari F, Stocek NB, Cole-André M,
Gomes J, Fanchini G, Pasternak SH, Christiansen G, Morshedi D,
Volkening K and Strong MJ: A methodological primer of extracellular
vesicles isolation and characterization via different techniques.
Biol Methods Protoc. 9:bpae0092024. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Knarr M, Avelar RA, Sekhar SC, Kwiatkowski
LJ, Dziubinski ML, McAnulty J, Skala S, Avril S, Drapkin R and
DiFeo A: miR-181a initiates and perpetuates oncogenic
transformation through the regulation of innate immune signaling.
Nat Commun. 11:32312020. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Wu M, Qiu Q, Zhou Q, Li J, Yang J, Zheng
C, Luo A, Li X, Zhang H, Cheng X, et al: circFBXO7/miR-96-5p/MTSS1
axis is an important regulator in the Wnt signaling pathway in
ovarian cancer. Mol Cancer. 21:1372022. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Luo L, Gao YQ and Sun XF: Circular RNA
ITCH suppresses proliferation and promotes apoptosis in human
epithelial ovarian cancer cells by sponging miR-10a-α. Eur Rev Med
Pharmacol Sci. 22:8119–8126. 2018.PubMed/NCBI
|
|
150
|
Ying X, Wu Q, Wu X, Zhu Q and Wang X,
Jiang L, Chen X and Wang X: Epithelial ovarian cancer-secreted
exosomal miR-222-3p induces polarization of tumor-associated
macrophages. Oncotarget. 7:43076–43087. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Cappellesso R, Tinazzi A, Giurici T,
Simonato F, Guzzardo V, Ventura L, Crescenzi M, Chiarelli S and
Fassina A: Programmed cell death 4 and microRNA 21 inverse
expression is maintained in cells and exosomes from ovarian serous
carcinoma effusions. Cancer Cytopathol. 122:685–693. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Meng X, Müller V, Milde-Langosch K,
Trillsch F, Pantel K and Schwarzenbach H: Diagnostic and prognostic
relevance of circulating exosomal miR-373, miR-200a, miR-200b and
miR-200c in patients with epithelial ovarian cancer. Oncotarget.
7:16923–16935. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Zavesky L, Jandakova E, Turyna R,
Langmeierova L, Weinberger V and Minar L: Supernatant versus
exosomal urinary microRNAs. Two fractions with different outcomes
in gynaecological cancers. Neoplasma. 63:121–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Zhou J, Gong G, Tan H, Dai F, Zhu X, Chen
Y, Wang J, Liu Y, Chen P, Wu X and Wen J: Urinary microRNA-30a-5p
is a potential biomarker for ovarian serous adenocarcinoma. Oncol
Rep. 33:2915–2923. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Hong JS, Son T, Castro CM and Im H:
CRISPR/Cas13a-based MicroRNA detection in tumor-derived
extracellular vesicles. Adv Sci (Weinh). 10:e23017662023.
View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Zhang L, Zhou Q, Qiu Q, Hou L, Wu M, Li J,
Li X, Lu B, Cheng X, Liu P, et al: CircPLEKHM3 acts as a tumor
suppressor through regulation of the miR-9/BRCA1/DNAJB6/KLF4/AKT1
axis in ovarian cancer. Mol Cancer. 18:1442019. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Li L, Zhang F, Zhang J, Shi X, Wu H, Chao
X, Ma S, Lang J, Wu M, Zhang D and Liang Z: Identifying serum small
extracellular vesicle MicroRNA as a noninvasive diagnostic and
prognostic biomarker for ovarian cancer. ACS Nano. 17:19197–19210.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Yu CC, Liao YW, Hsieh PL and Chang YC:
Targeting lncRNA H19/miR-29b/COL1A1 axis impedes myofibroblast
activities of precancerous oral submucous fibrosis. Int J Mol Sci.
22:22162021. View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Záveský L, Jandáková E, Turyna R,
Langmeierová L, Weinberger V, Záveská Drábková L, Hůlková M,
Hořínek A, Dušková D, Feyereisl J, et al: Evaluation of cell-free
urine microRNAs expression for the use in diagnosis of ovarian and
endometrial cancers. A pilot study. Pathol Oncol Res. 21:1027–1035.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Wang LL, Sun KX, Wu DD, Xiu YL, Chen X,
Chen S, Zong ZH, Sang XB, Liu Y and Zhao Y: DLEU1 contributes to
ovarian carcinoma tumourigenesis and development by interacting
with miR-490-3p and altering CDK1 expression. J Cell Mol Med.
21:3055–3065. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Dong L and Hui L: HOTAIR promotes
proliferation, migration, and invasion of ovarian cancer SKOV3
cells through regulating PIK3R3. Med Sci Monit. 22:325–331. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Zhang Y, Dun Y, Zhou S and Huang XH:
LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells
proliferation and invasion by targeting miR-133a-3p and activating
Wnt/β-catenin signaling pathway. Biomed Pharmacother. 96:1216–1221.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Wang J, Tian Y, Zheng H, Ding Y and Wang
X: An integrated analysis reveals the oncogenic function of lncRNA
LINC00511 in human ovarian cancer. Cancer Med. 8:3026–3035. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
164
|
An J, Lv W and Zhang Y: LncRNA NEAT1
contributes to paclitaxel resistance of ovarian cancer cells by
regulating ZEB1 expression via miR-194. Onco Targets Ther.
10:5377–5390. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Cao Y, Shi H, Ren F, Jia Y and Zhang R:
Long non-coding RNA CCAT1 promotes metastasis and poor prognosis in
epithelial ovarian cancer. Exp Cell Res. 359:185–194. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Yiwei T, Hua H, Hui G, Mao M and Xiang L:
HOTAIR interacting with MAPK1 regulates ovarian cancer skov3 cell
proliferation, migration, and invasion. Med Sci Monit.
21:1856–1863. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Yan H, Silva MA, Li H, Zhu L, Li P, Li X,
Wang X, Gao J, Wang P and Zhang Z: Long noncoding RNA DQ786243
interacts with miR-506 and promotes progression of ovarian cancer
through targeting cAMP responsive element binding protein 1. J Cell
Biochem. 119:9764–9780. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Duan M, Fang M, Wang C, Wang H and Li M:
LncRNA EMX2OS induces proliferation, invasion and sphere formation
of ovarian cancer cells via regulating the miR-654-3p/AKT3/PD-L1
axis. Cancer Manag Res. 12:2141–2154. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Yang M, Zhai Z, Zhang Y and Wang Y:
Clinical significance and oncogene function of long noncoding RNA
HAGLROS overexpression in ovarian cancer. Arch Gynecol Obstet.
300:703–710. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Wang Y, Zhang W, Wang Y and Wang S:
HOXD-AS1 promotes cell proliferation, migration and invasion
through miR-608/FZD4 axis in ovarian cancer. Am J Cancer Res.
8:170–182. 2018.PubMed/NCBI
|
|
171
|
Jin Y, Feng SJ, Qiu S, Shao N and Zheng
JH: LncRNA MALAT1 promotes proliferation and metastasis in
epithelial ovarian cancer via the PI3K-AKT pathway. Eur Rev Med
Pharmacol Sci. 21:3176–3184. 2017.PubMed/NCBI
|
|
172
|
Liu Y, Wang Y, Fu X and Lu Z: Long
non-coding RNA NEAT1 promoted ovarian cancer cells' metastasis
through regulation of miR-382-3p/ROCK1 axial. Cancer Sci.
109:2188–2198. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Ding C, Wei R, Rodríguez RA and Del Mar
Requena Mullor M: LncRNA PCAT-1 plays an oncogenic role in
epithelial ovarian cancer by modulating cyclinD1/CDK4 expression.
Int J Clin Exp Pathol. 12:2148–2156. 2019.PubMed/NCBI
|
|
174
|
Özeş AR, Miller DF, Özeş ON, Fang F, Liu
Y, Matei D, Huang T and Nephew KP: NF-κB-HOTAIR axis links DNA
damage response, chemoresistance and cellular senescence in ovarian
cancer. Oncogene. 35:5350–5361. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
175
|
Song R, Liu Z, Lu L, Liu F and Zhang B:
Long noncoding RNA SCAMP1 targets miR-137/CXCL12 axis to boost cell
invasion and angiogenesis in ovarian cancer. DNA Cell Biol.
39:1041–1050. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
176
|
Chen S, Wang LL, Sun KX, Xiu YL, Zong ZH,
Chen X and Zhao Y: The role of the long non-coding RNA TDRG1 in
epithelial ovarian carcinoma tumorigenesis and progression through
miR-93/RhoC pathway. Mol Carcinog. 57:225–234. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
177
|
Mu Y, Li N and Cui YL: The lncRNA CCAT1
upregulates TGFβR1 via sponging miR-490-3p to promote TGFβ1-induced
EMT of ovarian cancer cells. Cancer Cell Int. 18:1452018.
View Article : Google Scholar : PubMed/NCBI
|
|
178
|
Li J, Li J, Huang Y, Deng X, Luo M, Wang
X, Hu H, Liu C and Zhong M: Long noncoding RNA H19 promotes
transforming growth factor-β-induced epithelial-mesenchymal
transition by acting as a competing endogenous RNA of miR-370-3p in
ovarian cancer cells. Onco Targets Ther. 11:427–440. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
179
|
Xu M, Zhou K, Wu Y, Wang L and Lu S:
Linc00161 regulated the drug resistance of ovarian cancer by
sponging microRNA-128 and modulating MAPK1. Mol Carcinog.
58:577–587. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
180
|
Pan L, Meng Q, Li H, Liang K and Li B:
LINC00339 promotes cell proliferation, migration, and invasion of
ovarian cancer cells via miR-148a-3p/ROCK1 axes. Biomed
Pharmacother. 120:1094232019. View Article : Google Scholar : PubMed/NCBI
|
|
181
|
Zou A, Liu R and Wu X: Long non-coding RNA
MALAT1 is up-regulated in ovarian cancer tissue and promotes
SK-OV-3 cell proliferation and invasion. Neoplasma. 63:865–872.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
182
|
Chang L, Guo R, Yuan Z, Shi H and Zhang D:
LncRNA HOTAIR regulates CCND1 and CCND2 expression by sponging
miR-206 in ovarian cancer. Cell Physiol Biochem. 49:1289–1303.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
183
|
Sun Q, Li Q and Xie F: LncRNA-MALAT1
regulates proliferation and apoptosis of ovarian cancer cells by
targeting miR-503-5p. Onco Targets Ther. 12:6297–6307. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
184
|
An Q, Liu T, Wang MY, Yang YJ, Zhang ZD,
Lin ZJ and Yang B: circKRT7-miR-29a-3p-COL1A1 axis promotes ovarian
cancer cell progression. Onco Targets Ther. 13:8963–8976. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
185
|
Wang F, Niu Y, Chen K, Yuan X, Qin Y,
Zheng F, Cui Z, Lu W, Wu Y and Xia D: Extracellular
vesicle-packaged circATP2B4 mediates M2 macrophage polarization via
miR-532-3p/SREBF1 axis to promote epithelial ovarian cancer
metastasis. Cancer Immunol Res. 11:199–216. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
186
|
Wu Y, Xu M, Feng Z, Wu H, Wu J, Ha X, Wu
Y, Chen S, Xu F, Wen H, et al: AUF1-induced circular RNA
hsa_circ_0010467 promotes platinum resistance of ovarian cancer
through miR-637/LIF/STAT3 axis. Cell Mol Life Sci. 80:2562023.
View Article : Google Scholar : PubMed/NCBI
|
|
187
|
Li H, Luo F, Jiang X, Zhang W, Xiang T,
Pan Q, Cai L, Zhao J, Weng D, Li Y, et al: CircITGB6 promotes
ovarian cancer cisplatin resistance by resetting tumor-associated
macrophage polarization toward the M2 phenotype. J Immunother
Cancer. 10:e0040292022. View Article : Google Scholar : PubMed/NCBI
|
|
188
|
Zou T, Wang PL, Gao Y and Liang WT:
Circular RNA_LARP4 is lower expressed and serves as a potential
biomarker of ovarian cancer prognosis. Eur Rev Med Pharmacol Sci.
22:7178–7182. 2018.PubMed/NCBI
|
